S1419
Interdisciplinary - Health economics & health services research
ESTRO 2026
Digital Poster 3516
Developing a resource optimized radiotherapy scheduling model (RORSM) to reduce waiting times in a Bangladeshi cancer center Nowshin Taslima Hossain 1 , A.H.M. Shariful Alam 1 , Altaf Mumtahina 1 , Tasfi Jahan Tina 1 , Bhaskor Chakraborty 1 , Sadia Sadiq 3 , Rajani Jha 4 , Sweta Soni 5 , Nazirum Mubin 6 , Sabiha Salsabil 6 , MD. Abul Ahsan Didar 7 , Md. Raihan Bin Sharif 7 , Md. Habibur Rahman 7 , M. Saiful Huq 8 1 Radiation Oncology, Ahsania Mission Cancer and General Hospital, Dhaka, Bangladesh. 2 Radiation Oncology, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh. 3 Radiation Oncology, INMOL Hospital, Lahore, Pakistan. 4 Radiation Oncology, Kathmundu Cancer Hospital, Kathmundu, Hossain 2 , Masudul Hasan Arup 1,2 , Aditi Paul Chowdhury 1 , Jannatul Ferdause 1 , Sura Jukrup Nepal. 5 Radiation Oncology, AIMS, Rajkot, India. 6 Radiotherapy, Dhaka Medical College, Dhaka, Bangladesh. 7 Medical Oncology, Ahsania Mission Cancer and General Hospital, Dhaka, Bangladesh. 8 Radiation Oncology, UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Purpose/Objective: Bangladesh faces a substantial cancer burden (GLOBOCAN 2022: 167,526 new cases/year) but has only ~39 radiotherapy machines nationwide, leading to prolonged treatment delays—up to 8 months in government centers. To address this, we developed and implemented the Resource-Optimized Radiotherapy Scheduling Model (RORSM) at a tertiary private cancer center to prioritize limited resources, reduce waiting times, and create a scalable national model. Material/Methods: From January to March 2024, baseline data on radiotherapy (RT) demand and capacity were collected. RORSM integrated four key components combining (1) Evidence-based hypofractionation templates (curative and palliative), e.g., breast cancer (25 → 15–5 fractions) and single-fraction (8 Gy) RT for bone metastases, (2) Clinical priority scoring (curative, adjuvant, palliative, emergency), (3) Pre-registration of RT at the initiation of systemic therapy (for breast, rectal, cervical, lung, and sarcoma cases) to eliminate post-chemotherapy delays, (4) Protected daily slots for new starts and emergencies. A greedy, priority-based scheduler and weekly multidisciplinary (MDT) scheduling huddles were used. Primary endpoints were median waiting time to RT initiation and monthly RT throughput. Secondary outcomes included hypofractionation adoption and machine utilization. A 3-month baseline period was compared with a 3- month post-implementation period.
Made with FlippingBook - Share PDF online